Topiramate and phenytoin anti-immobility effect in the mice forced swimming test is reversed by veratrine: Implication for bipolar depression treatment

Behavioural Brain Research

Volumn 205, Issue 2, 2009, Pages 421-425

  Bourin, Michel ^a   Chenu, Franck ^a   Hascoët, Martine ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Bipolar depression; FST; Phenytoin; Sodium channels; Topiramate; Veratrine

Indexed keywords

ANTICONVULSIVE AGENT; CEVADINE; PHENYTOIN; SODIUM CHANNEL; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BIPOLAR DEPRESSION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; EXPERIMENTAL DESIGN; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; LOCOMOTION; MALE; MEMBRANE TRANSPORT MODULATORS; MICE; NEUROPSYCHOLOGICAL TESTS; PHENYTOIN; RANDOM ALLOCATION; SODIUM CHANNELS; SWIMMING; TIME FACTORS; VERATRINE;

EID: 70349776041     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.07.030     Document Type: Article

References (29)

1. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., and Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60 (1999) 79-88
2. Calabrese J.R., Hirschfeld R.M., Frye M.A., and Reed M.L. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry 65 (2004) 1499-1504
3. Cestele S., and Catterall W.A. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82 (2000) 883-892
4. Cheung H., Kamp D., and Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13 (1992) 107-112
5. Cunningham M.O., and Jones R.S. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39 (2000) 2139-2146
6. Dickie B.G., and Davies J.A. Modulation of calcium-dependent and -independent components of veratridine-evoked release of glutamate from rat cerebellum. Brain Res 619 (1993) 247-254
7. Gao K., Gajwani P., Elhaj O., and Calabrese J.R. Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry 66 (2005) 1376-1385
8. Hargreaves G.A., and Mc Gregor I.S. Serikawa, Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res 31 (2007) 1900-1907
9. Kanda T., Kurokawa M., Tamura S., Nakamura J., Ishii A., Kuwana Y., et al. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER). Life Sci 59 (1996) 1607-1616
10. Liu D., Thangnipon W., and McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 547 (1991) 344-348
11. Liu D., Xu G.Y., Pan E., and McAdoo D.J. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 93 (1999) 1383-1389
12. Matsuki N., Quandt F.N., Ten Eick R.E., and Yeh J.Z. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther 228 (1984) 523-530
13. McIntyre R.S., Mancini D.A., McCann S., Srinivasan J., Sagman D., and Kennedy S.H. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 4 (2002) 207-213
14. Millan M.J. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics 6 (2009) 53-77
15. Mishory A., Winokur M., and Bersudsky Y. Prophylactic effect of phenytoin in bipolar disorder: a controlled study. Bipolar Disord 5 (2003) 464-467
16. Mishory A., Yaroslavsky Y., Bersudsky Y., and Belmaker R.H. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 157 (2000) 463-465
17. Petit-Demouliere B., Chenu F., and Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177 (2005) 245-255
18. Petroff O.A., Hyder F., Mattson R.H., and Rothman D.L. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 52 (1999) 473-478
19. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
20. Prakriya M., and Mennerick S. Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26 (2000) 671-682
21. Prica C., Hascoet M., and Bourin M. Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression. Behav Brain Res 191 (2008) 49-54
22. Prica C., Hascoet M., and Bourin M. Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?. Behav Brain Res 194 (2008) 92-99
23. Sitges M., Chiu L.M., Guarneros A., and Nekrassov V. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52 (2007) 598-605
24. 2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 53 (2007) 854-862
25. Szymczyk G., and Zebrowska-Lupina I. Influence of antiepileptics on efficacy of antidepressant drugs in the forced swimming test. Pol J Pharmacol 52 (2000) 44
26. Waldmeier P.C., Martin P., Stocklin K., Portet C., and Schmutz M. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn Schmiedebergs Arch Pharmacol 354 (1996) 164-172
27. Wang S.Y., and Wang G.K. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal 15 (2003) 151-159
28. Xie X., Dale T.J., John V.H., Cater H.L., Peakman T.C., and Clare J.J. Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch 441 (2001) 425-433
29. Yatham L.N. Newer anticonvulsants in the treatment of bipolar disorder. J Clin Psychiatry 65 Suppl. 10 (2004) 28-35